Abstract
Nitrogen-containing bisphosphonates indirectly activate Vgamma9Vdelta2 T cells through inhibition of farnesyl pyrophosphate synthase and intracellular accumulation of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), but the cells responsible for Vgamma9Vdelta2 T cell activation through IPP/DMAPP accumulation are unknown. Treatment of human peripheral blood mononuclear cells (PBMCs) with a pharmacologically relevant concentration of zoledronic acid induced accumulation of IPP/DMAPP selectively in monocytes, which correlated with efficient drug uptake by these cells. Furthermore, zoledronic acid-pulsed monocytes triggered activation of gammadelta T cells in a cell contact-dependent manner. These observations identify monocytes as the cell type directly affected by bisphosphonates responsible for Vgamma9Vdelta2 T cell activation.
| Original language | English |
|---|---|
| Pages (from-to) | 245-50 |
| Number of pages | 6 |
| Journal | British journal of haematology |
| Volume | 144 |
| Issue number | 2 |
| Early online date | 17 Dec 2008 |
| DOIs | |
| Publication status | Published - Jan 2009 |
Keywords / Materials (for Non-textual outputs)
- Cell Communication
- Cells, Cultured
- Diphosphonates/pharmacology
- Hemiterpenes/metabolism
- Humans
- Imidazoles/pharmacology
- Lymphocyte Activation
- Monocytes/drug effects
- Organophosphorus Compounds/metabolism
- Receptors, Antigen, T-Cell, gamma-delta/immunology
- T-Lymphocytes/drug effects
- Zoledronic Acid